Articulo
Cascade ligand- and structure-based virtual screening to identify new trypanocidal compounds inhibiting putrescine uptake
Autor
Alberca, Lucas Nicolás
Sbaraglini, María Laura
Morales, Juan Francisco
Dietrich, Roque Carlos
Ruiz, María Daniela
Pino Martínez, Agustina María
Miranda, Cristian Gabriel
Fraccaroli, Laura Virginia
Alba Soto, Catalina Dirney
Carrillo, Carolina
Palestro, Pablo Hernán
Talevi, Alan
Institución
Resumen
Chagas disease is a neglected tropical disease endemic to Latin America, though migratory movements have recently spread it to other regions. Here, we have applied a cascade virtual screening campaign combining ligand- and structure-based methods. In order to find novel inhibitors of putrescine uptake in <i>Trypanosoma cruzi</i>, an ensemble of linear ligand-based classifiers obtained by has been applied as initial screening filter, followed by docking into a homology model of the putrescine permease <i>Tc</i>PAT12. 1,000 individual linear classifiers were inferred from a balanced dataset. Subsequently, different schemes were tested to combine the individual classifiers: MIN operator, average ranking, average score, average voting, with MIN operator leading to the best performance. The homology model was based on the arginine/agmatine antiporter (AdiC) from <i>Escherichia coli</i> as template. It showed 64% coverage of the entire query sequence and it was selected based on the normalized Discrete Optimized Protein Energy parameter and the GA341 score. The modeled structure had 96% in the allowed area of Ramachandran's plot, and none of the residues located in non-allowed regions were involved in the active site of the transporter. Positivity Predictive Value surfaces were applied to optimize the score thresholds to be used in the ligand-based virtual screening step: for that purpose Positivity Predictive Value was charted as a function of putative yields of active in the range 0.001-0.010 and the Se/Sp ratio. With a focus on drug repositioning opportunities, DrugBank and Sweetlead databases were subjected to screening. Among 8 hits, cinnarizine, a drug frequently prescribed for motion sickness and balance disorder, was tested against <i>T. cruzi</i> epimastigotes and amastigotes, confirming its trypanocidal effects and its inhibitory effects on putrescine uptake. Furthermore, clofazimine, an antibiotic with already proven trypanocidal effects, also displayed inhibitory effects on putrescine uptake. Two other hits, meclizine and butoconazole, also displayed trypanocidal effects (in the case of meclizine, against both epimastigotes and amastigotes), without inhibiting putrescine uptake. Facultad de Ciencias Exactas Laboratorio de Investigación y Desarrollo de Bioactivos